Katarzyna Kaczyńska Selected Research

Opioid Receptors (Opioid Receptor)

11/2020	Intracerebroventricular Neuropeptide FF Diminishes the Number of Apneas and Cardiovascular Effects Produced by Opioid Receptors' Activation.
10/2020	Vagal apnea and hypotension evoked by systemic injection of an antinociceptive analogue of endomorphin-2.
2/2017	Cardiovascular and respiratory activity of PK20, opioid and neurotensin hybrid peptide in anesthetized and awake rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katarzyna Kaczyńska Research Topics

Disease

7	Asthma (Bronchial Asthma) 12/2021 - 01/2018
5	Apnea 04/2024 - 01/2006
5	Hypoxia (Hypoxemia) 05/2022 - 03/2017
4	Parkinson Disease (Parkinson's Disease) 05/2023 - 03/2017
4	Inflammation (Inflammations) 12/2021 - 10/2016
3	Hypercapnia 04/2024 - 05/2022
3	Respiratory Insufficiency (Respiratory Failure) 12/2021 - 03/2010
3	Hypotension (Low Blood Pressure) 10/2020 - 09/2007
2	Alzheimer Disease (Alzheimer's Disease) 06/2023 - 05/2022
2	Lung Diseases (Lung Disease) 01/2023 - 07/2020
2	Obstructive Sleep Apnea 01/2021 - 01/2018
2	Bradycardia 10/2020 - 12/2015
1	Parkinsonian Disorders (Parkinsonism) 05/2023
1	Cognitive Dysfunction 05/2022
1	Respiratory Hypersensitivity 01/2021
1	Neoplasms (Cancer) 02/2019
1	Occupational Asthma 12/2018
1	Contact Dermatitis (Eczema, Contact) 10/2016
1	Hypersensitivity (Allergy) 10/2016
1	Body Weight (Weight, Body) 12/2013
1	Fibrosis (Cirrhosis) 12/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2013
1	Infections 01/2012
1	Tachycardia (Tachyarrhythmias) 01/2011
1	Hypertension (High Blood Pressure) 01/2011
1	Hypoventilation 03/2010
1	Hyperventilation 08/2002

Drug/Important Bio-Agent (IBA)

5	NeurotensinIBA 12/2021 - 10/2016
5	HaptensIBA 07/2020 - 10/2016
4	salicylhydroxamic acid (SHAM)IBA 04/2024 - 07/2017
4	Peptides (Polypeptides)IBA 12/2021 - 10/2016
4	Opioid Analgesics (Opioids)IBA 12/2021 - 10/2016
3	Serotonin (5 Hydroxytryptamine)IBA 04/2024 - 03/2017
3	Oxidopamine (6 Hydroxydopamine)IBA 04/2024 - 07/2017
3	Dopamine (Intropin)FDA LinkGeneric 04/2024 - 01/2021
3	Opioid Receptors (Opioid Receptor)IBA 11/2020 - 02/2017
3	endomorphin 2IBA 10/2020 - 10/2016
3	DinitrofluorobenzeneIBA 07/2020 - 10/2016
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2024 - 01/2021
2	AcetylcholinesteraseIBA 06/2023 - 05/2022
2	Reserpine (Serpasil)FDA Link 05/2023 - 01/2021
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2022 - 01/2006
2	CytokinesIBA 01/2021 - 07/2020
1	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 04/2024
1	GoldIBA 06/2023
1	Levodopa (L Dopa)FDA LinkGeneric 05/2023
1	LactoferrinIBA 01/2023
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 05/2022
1	Rivastigmine (Exelon)FDA LinkGeneric 05/2022
1	Memantine (Namenda)FDA Link 05/2022
1	Neuropeptide YIBA 12/2021
1	DefensinsIBA 12/2021
1	TachykininsIBA 12/2021
1	Peptide Receptors (Peptide Receptor)IBA 12/2021
1	Phospholipases (Phospholipase)IBA 01/2021
1	Biogenic Amines (Biogenic Amine)IBA 01/2021
1	Malondialdehyde (Propanedial)IBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2021
1	Neurotensin Receptors (Neurotensin Receptor)IBA 01/2021
1	phenylalanyl- leucyl- phenylalanyl- glutaminyl- prolyl- glutaminyl- arginyl- phenylalaninamideIBA 11/2020
1	Interleukin-6 (Interleukin 6)IBA 07/2020
1	SolutionsIBA 07/2020
1	SaltsIBA 07/2020
1	brineIBA 07/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2019
1	sulforaphaneIBA 02/2019
1	NeuropeptidesIBA 01/2018
1	5-HT2 Serotonin ReceptorsIBA 03/2017
1	neurotensin (8-13)IBA 10/2016
1	Sincalide FDA Link 12/2015
1	sodium iodateIBA 12/2013
1	Retinaldehyde (Retinal)IBA 12/2013
1	ElastinIBA 12/2013
1	CollagenIBA 12/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2012
1	Phentolamine (Z-Max)FDA LinkGeneric 01/2011
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2011
1	BombesinIBA 01/2011
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2010
1	1- (2- methoxyphenyl)- 4- (4- (2- phthalimido)butyl)piperazineIBA 09/2007
1	2-amino-7-phosphonoheptanoic acidIBA 01/2006
1	N-Methylaspartate (NMDA)IBA 01/2006
1	gamma-Aminobutyric Acid (GABA)IBA 08/2002

Therapy/Procedure

6	Therapeutics 01/2023 - 01/2012
2	Vagotomy 03/2010 - 01/2006
1	Analgesia 11/2020
1	Intravenous Administration 02/2017
1	Intravitreal Injections 12/2013